✦ LIBER ✦

Variations in practice and outcomes in patients undergoing primary percutaneous coronary intervention in the United States and Canada: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI) trial

✍ Scribed by Rajendra H. Mehta; Padma Kaul; Renato D. Lopes; Manesh R. Patel; Yinggan Zheng; Karen S. Pieper; Robert C. Welsh; Paul W. Armstrong; Christopher B. Granger

Book ID: 116192753
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 146 KB
Volume: 163
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2012.03.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ST-Segment Recovery and Outcome After Pr

ST-Segment Recovery and Outcome After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Insights From the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial

✍ Buller, C. E.; Fu, Y.; Mahaffey, K. W.; Todaro, T. G.; Adams, P.; Westerhout, C. 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 559 KB

Pexelizumab fails to inhibit assembly of

Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial

✍ Catherine Martel; Christopher B. Granger; Marta Ghitescu; Amanda Stebbins; Annik 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 594 KB

Assessment of Pexelizumab in Acute Myoca

Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention

✍ Paul W. Armstrong; Peter X. Adams; Hussein R. Al-Khalidi; Christian Hamm; David 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Predictors of Reperfusion Delay in Patie

Predictors of Reperfusion Delay in Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention from the HORIZONS-AMI Trial

✍ James C. Blankenship; Kimberly A. Skelding; Thomas D. Scott; Peter B. Berger; He 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Is visual interpretation of coronary epi

Is visual interpretation of coronary epicardial flow reliable in patients with ST-elevation myocardial infarction undergoing primary angioplasty? Insights from the angiographic substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial

✍ Osama Alhadramy; Cynthia M. Westerhout; Sorin J. Brener; Christopher B. Granger; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 320 KB

Does silent myocardial infarction add pr

Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction patients without a history of prior myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial

✍ Mustafa Toma; Yuling Fu; Justin A. Ezekowitz; Finlay A. McAlister; Cynthia M. We 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 337 KB